Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesASH position paper: Dietary approaches to lower blood pressure
The Journal of Clinical Hypertension, 06/25/09
Appel LJ et al. – An ASH position paper on dietary approaches to lower blood pressure (BP) focuses on dietary risk factors; race- and age-related risks; effects on nonhypertensive and hypertensive pts; and current challenges of clinical and public health interventions.
Methods- ASH position paper on dietary approaches to lower BP
- Well-established dietary risk factors for elevated BP: excess salt intake, low potassium intake, excess weight, high alcohol consumption, and suboptimal dietary pattern
- African Americans especially sensitive to BP effects of excess salt intake, insufficient potassium intake, and suboptimal diet
- Direct, progressive relationship of BP with cardiovascular-renal diseases throughout usual range of BP, and world epidemic of BP-related disease warrants efforts to reduce BP in nonhypertensive and hypertensive pts
- Lower BP and hypertension delay/prevention for nonhypertensive pts with dietary changes
- Dietary changes serve as initial treatment before drug therapy for uncomplicated stage I hypertension
- Lifestyle modifications can further lower BP in hypertensive pts already on drug therapy
- Current challenge: effective clinical and public health interventions for sustained dietary changes among pts and the general population
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension
Journal of Human Hypertension, 11/10/09
Sponsor
Article Search
Sponsor